The Recall Desk

Manufacturer

VIRTUS PHARMACEUTICALS OPCO II L

7 recalls in our database name VIRTUS PHARMACEUTICALS OPCO II L as the manufacturing or recalling firm.

What the numbers show

Total
7
Critical
0
Severe
3
Most recent
2017-01-04

Of the 7 recalls from VIRTUS PHARMACEUTICALS OPCO II L we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3 (43%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–7 of 7

  • ModerateFDA (Drugs)·D-0240-2017·2017-01-04

    Virtus Pharmaceuticals Recalls Virt-Select Prenatal Softgels Due to GMP Deviations

    Virtus Pharmaceuticals is recalling Virt-Select Prenatal/Postnatal Softgels because the active ingredient manufacturer is on an FDA Import Alert for cGMP deviations.

    Product
    Virt-Select Prenatal/Postnatal Softgels, Prescription Multivitamin/Mineral Dietary Supplement with Fish-Based DHA , packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-249-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0238-2017·2017-01-04

    Virt-Advance Prenatal Softgels Recalled Due to API Manufacturer Import Alert

    Virtus Pharmaceuticals is recalling Virt-Advance Prenatal/Postnatal Softgels because the active ingredient manufacturer is on an FDA Import Alert.

    Product
    Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, packaged in 90-count bottle, Rx only, Made in Canada, NDC 76439-357-90
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0241-2017·2017-01-04

    VirtPrex Prenatal Tablets Recalled Due to API Manufacturer Import Alert

    Virtus Pharmaceuticals is recalling VirtPrex Prenatal/Postnatal Tablets because the active ingredient manufacturer is on an FDA Import Alert.

    Product
    VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0239-2017·2017-01-04

    Virtus Pharmaceuticals Recalls Extra-Virt Plus DHA Prenatal Softgels

    Virtus Pharmaceuticals is recalling 2,406 bottles of Extra-Virt Plus DHA Prenatal/Postnatal Softgels because the API manufacturer is on FDA Import Alert.

    Product
    Extra-Virt Plus DHA Prenatal/Postnatal Softgel, Prescription Multivitamin/Mineral Dietary Supplement with Fish-Based DHA , packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-251-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0213-2017·2016-12-28

    Virtus Recalls Hyoscyamine Sulfate Tablets Due to Content Uniformity Failures

    Virtus Pharmaceuticals is recalling Hyoscyamine Sulfate tablets because they failed content uniformity specifications, resulting in both superpotent and subpotent doses.

    Product
    Hyoscyamine Sulfate, Orally Disintegrating Tablets, 0.125 mg, 100-count bottles, Rx only, Manufactured for: Virtus Pharmaceuticals OPCO II, LLC., Nashville, TN 37217, NDC 76439-307-10.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0214-2017·2016-12-28

    Virtus Recalls Hyoscyamine Sulfate Tablets Due to Potency Failures

    Virtus Pharmaceuticals is recalling 24,444 bottles of Hyoscyamine Sulfate tablets because they failed content uniformity specifications, resulting in inconsistent drug potency.

    Product
    Hyoscyamine Sulfate, USP Tablets, 0.125 mg, 100-count tablets per bottle, Rx only, Manufactured for: Virtus Pharmaceuticals OPCO II, LLC., Nashville, TN 37217, NDC 76439-308-10.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0212-2017·2016-12-28

    Virtus Recalls Hyoscyamine Sulfate Tablets Due to Content Uniformity Failures

    Virtus Pharmaceuticals is recalling Hyoscyamine Sulfate sublingual tablets because they failed content uniformity specifications, resulting in tablets that are either superpotent or subpotent.

    Product
    Hyoscyamine Sulfate, Sublingual Tablets, 0.125 mg, 100-count bottle, Rx only, Manufactured for: Virtus Pharmaceuticals OPCO II, LLC., Nashville, TN 37217, NDC 76439-309-10.
    Category
    Drug
    Distribution
    Distributed nationwide